What is Fosamax?

Fosamax (alendronate sodium) manufactured by (Merck & Company) it belongs to a class of medications called bisphosphonates, and they decrease the activity of cells which break down bone. It is marketed alone as well as in combination with vitamin D. Fosamax was approved by the FDA in September, 1995

What is Fosamax prescribed for?

Fosamax is a prescription medicine for the treatment or prevention of osteoporosis (thinning of bone) in women after menopause. It reduces the chance of having a hip or spinal fracture (break). Other uses include treatment to increase bone mass in men with osteoporosis and the treatment of osteoporosis in either men or women who are taking corticosteroid medicines.

What are the dangers associated with Fosamax?

Recently the Journal of Oral and Maxillofacial Surgeons reported a link between bisphosphonates and a serious bone disease called osteonecrosis of the jaw (ONJ). Osteonecrosis is a disfiguring and disabling condition of the jaw bone that causes infection and rotting of the jaw bone. Typical presentation of Osteonecrosis is pain, soft-tissue swelling and infection, loosening of teeth, drainage, and exposed bone. Symptoms may occur spontaneously, or at the site of previous tooth extraction.

The US Food and Drug Administration and the manufacturer of Fosamax issued a warning to health care professionals on September 24, 2004 of the danger associated with the use of this drug.

What can I do if I have been injured by Fosamax?

If you or a loved one has suffered Osteonecrosis of the Jaw (ONJ) or any other serious side effect as the result of taking Fosamax, you may be entitled to compensation. For a free legal consultation, contact us today!